In hepatocellular carcinoma, there is a positive correlation between CXCL6 and CD163 expression in patient samples, and TAMs promote cancer cell proliferation and migration by activating CXCR2/IFN-g/p38 MAPK/NF-κB signaling [135]. Here, CD163 is linked to hepatocellular carcinoma.